approval
saveONTRUZANT (TRASTUZUMAB-DTTB) — FDA approval
community read0 votes
Sponsor: SAMSUNG BIOEPIS CO LTD. Form: POWDER. Route: IV (INFUSION)
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 4
same company · ±60 days · 6
- approvalEPYSQLI: EPYSQLI (ECULIZUMAB-AAGH) — FDA approvalMar 12, 2025
- approvalPYZCHIVA: PYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalMar 13, 2025
- approvalPYZCHIVA: PYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalMar 13, 2025
- approvaldenosumab biosimilar: DENOSUMAB-DSSB — FDA approvalFeb 13, 2025
- approvalEPYSQLI: EPYSQLI (ECULIZUMAB-AAGH) — FDA approvalJan 28, 2025
- approvalEPYSQLI: EPYSQLI (ECULIZUMAB-AAGH) — FDA approvalJan 21, 2025
comments(0)
5-min edit window · permanent after that